- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02297750
Optimal Timing of Double-Wire Technique For Biliary Cannulation at ERCP
October 23, 2015 updated by: Duke University
The purpose of this study is to give doctors who perform Endoscopic Retrograde Cholangiopancreatography (ERCP) procedures a better idea as to the best techniques to use in order to examine the bile duct as quickly and safely as possible.
Study Overview
Status
Completed
Detailed Description
Sometimes, in the course of a regular ERCP procedure, techniques used by the doctor to pass a wire into the bile duct can result in the pancreas duct being entered instead.
When this happens, the doctor may either remove the wire (known as "single wire" technique) or leave it in and use a second wire ("double wire") to enter the bile duct.
This study will try to determine whether the "double wire" technique or the "single wire" technique removing the wire is the safest and most efficient.
Study Type
Interventional
Enrollment (Actual)
161
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27710
- Duke University Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients undergoing ERCP with primary intent to cannulate the bile duct
- Written informed consent
Exclusion Criteria:
- Age < 18 years
- Non-naive papilla (previous sphincterotomy)
- Surgically altered anatomy
- Known/suspected pancreas divisum
- Suspected SOD/biliary manometry
- Prior ERCP/stent within 3 months
- ERCP performed in the Operating Room or at Duke North
- Pregnancy/breast-feeding
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: single wire technique
single wire technique in patients undergoing ERCP with biliary cannulation
|
|
Active Comparator: Double wire technique
double-wire technique in patients undergoing ERCP with biliary cannulation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Success of biliary cannulation
Time Frame: 10 minutes after randomization
|
The primary outcome is incidence of successful deep biliary cannulation within 10 minutes.
|
10 minutes after randomization
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Success of biliary cannulation
Time Frame: 2 days after the procedure
|
Number of attempts required for successful biliary cannulation
|
2 days after the procedure
|
Time to successful biliary cannulation
Time Frame: 2 days after the procedure
|
2 days after the procedure
|
|
Post-ERCP pancreatitis
Time Frame: 2 days after the procedure
|
2 days after the procedure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Mahfuzul Haque, MD, Duke University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2012
Primary Completion (Actual)
June 1, 2015
Study Completion (Actual)
June 1, 2015
Study Registration Dates
First Submitted
November 19, 2014
First Submitted That Met QC Criteria
November 20, 2014
First Posted (Estimate)
November 21, 2014
Study Record Updates
Last Update Posted (Estimate)
October 26, 2015
Last Update Submitted That Met QC Criteria
October 23, 2015
Last Verified
November 1, 2014
More Information
Terms related to this study
Other Study ID Numbers
- Pro00033706
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Endoscopic Retrograde Cholangiopancreatography
-
Indiana UniversityCompletedCholangiopancreatography, Endoscopic RetrogradeUnited States
-
Boston Scientific CorporationCompletedEndoscopic Retrograde CholangiopancreatographyUnited States, Netherlands
-
Helsinki University Central HospitalCompletedEndoscopic Retrograde CholangiopancreatographyFinland
-
Ambu A/SAmbu Inc.; Infinite Clinical Solutions; Prelude DynamicsCompletedEndoscopic Retrograde Cholangiopancreatography (ERCP)United States
-
Kliniken Ludwigsburg-Bietigheim gGmbHNot yet recruitingCholangiopancreatography, Endoscopic Retrograde
-
Olympus Europe SE & Co. KGTerminatedCholangiopancreatography, Endoscopic RetrogradeBelgium, Germany, Norway
-
Boston Scientific CorporationCompletedEndoscopic Retrograde CholangiopancreatographyUnited States
-
Helsinki University Central HospitalTurku University Hospital; Oulu University HospitalCompletedEndoscopic Retrograde CholangiopancreatographyFinland
-
University Hospital, LinkoepingCompletedEndoscopic Retrograde CholangiopancreatographySweden
-
AdventHealthCompletedEndoscopic Retrograde CholangiopancreatographyUnited States